Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in INMB — Inmune Bio, Inc.

CIK 1214717 BOSTON, MA
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$310,049
-$249,265 QoQ
Shares Held
190,215
-61.6% QoQ
Ownership
0.685%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 83 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. INMB ranks #383 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in INMB

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $310,049 190,215
2026-03-31 $559,314 494,969
2025-12-31 $688,973 441,650
2025-09-30 $971,740 469,440
2025-06-30 $900,739 389,931
2025-03-31 $2,849,572 364,862
2024-12-31 $1,698,021 363,602
2024-09-30 $1,856,670 344,466
2024-06-30 $2,850,659 323,204
2024-03-31 $2,006,923 170,802
2023-12-31 $1,914,650 170,040
2023-09-30 $1,131,287 167,103
2023-06-30 $1,404,494 154,680
2023-03-31 $928,024 143,657
2022-12-31 $906,600 142,997
2022-09-30 $865,557 139,606
2022-06-30 $1,221,900 138,224
2022-03-31 $1,073,794 127,529
2021-12-31 $1,206,354 118,270
2021-09-30 $1,740,167 89,607
2021-06-30 $1,296,560 73,794
2021-03-31 $722,743 60,837
2020-12-31 $579,539 33,655
2020-09-30 $309,537 30,023